Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

245 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intestinal microbiota controls graft-versus-host disease independent of donor-host genetic disparity.
Koyama M, Hippe DS, Srinivasan S, Proll SC, Miltiadous O, Li N, Zhang P, Ensbey KS, Hoffman NG, Schmidt CR, Yeh AC, Minnie SA, Strenk SM, Fiedler TL, Hattangady N, Kowalsky J, Grady WM, Degli-Esposti MA, Varelias A, Clouston AD, van den Brink MRM, Dey N, Randolph TW, Markey KA, Fredricks DN, Hill GR. Koyama M, et al. Among authors: hippe ds. Immunity. 2023 Aug 8;56(8):1876-1893.e8. doi: 10.1016/j.immuni.2023.06.024. Epub 2023 Jul 21. Immunity. 2023. PMID: 37480848
Increased risk of recurrence and disease-specific death following delayed postoperative radiation for Merkel cell carcinoma.
Alexander NA, Schaub SK, Goff PH, Hippe DS, Park SY, Lachance K, Bierma M, Liao JJ, Apisarnthanarax S, Bhatia S, Tseng YD, Nghiem PT, Parvathaneni U. Alexander NA, et al. Among authors: hippe ds. J Am Acad Dermatol. 2024 Feb;90(2):261-268. doi: 10.1016/j.jaad.2023.07.1047. Epub 2023 Sep 30. J Am Acad Dermatol. 2024. PMID: 37778663
Correction to: Extended duration of treatment using reduced‑frequency dosing of anti‑PD‑1 therapy in patients with advanced melanoma and Merkel cell carcinoma.
Tachiki LML, Hippe DS, Silva KW, Hall ET, McCamy W, Fritzsche D, Perdue A, Majovski J, Pulliam T, Goldstein DA, Veatch J, Ho J, Nghiem PT, Thompson JA, Bhatia S. Tachiki LML, et al. Among authors: hippe ds. Cancer Immunol Immunother. 2023 Dec;72(12):4471. doi: 10.1007/s00262-023-03575-4. Cancer Immunol Immunother. 2023. PMID: 37979010 Free PMC article. No abstract available.
Extended duration of treatment using reduced-frequency dosing of anti-PD-1 therapy in patients with advanced melanoma and Merkel cell carcinoma.
Tachiki LML, Hippe DS, Williams Silva K, Hall ET, McCamy W, Fritzsche D, Perdue A, Majovski J, Pulliam T, Goldstein DA, Veatch J, Ho J, Nghiem PT, Thompson JA, Bhatia S. Tachiki LML, et al. Among authors: hippe ds. Cancer Immunol Immunother. 2023 Nov;72(11):3839-3850. doi: 10.1007/s00262-023-03539-8. Epub 2023 Sep 21. Cancer Immunol Immunother. 2023. PMID: 37733060 Free PMC article.
245 results